Neovascular suppressors such as PF4, collagen type I, and IP-10 are increased in specimens removed from patients with CTEPH after PEA, which may result in inadequate thrombus recanalization [35]. This evidence concerns the gene PF4 and chronic thromboembolic pulmonary hypertension.